JP2009506994A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506994A5 JP2009506994A5 JP2008528372A JP2008528372A JP2009506994A5 JP 2009506994 A5 JP2009506994 A5 JP 2009506994A5 JP 2008528372 A JP2008528372 A JP 2008528372A JP 2008528372 A JP2008528372 A JP 2008528372A JP 2009506994 A5 JP2009506994 A5 JP 2009506994A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- integer
- ono
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 18
- 125000000217 alkyl group Chemical group 0.000 claims 16
- 229910052731 fluorine Inorganic materials 0.000 claims 11
- 125000001153 fluoro group Chemical group F* 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 8
- 238000000034 method Methods 0.000 claims 8
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 5
- 239000000460 chlorine Substances 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 5
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 239000002904 solvent Substances 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000006832 (C1-C10) alkylene group Chemical group 0.000 claims 4
- 206010015150 Erythema Diseases 0.000 claims 4
- ZCCIPPOKBCJFDN-UHFFFAOYSA-N calcium nitrate Chemical compound [Ca+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ZCCIPPOKBCJFDN-UHFFFAOYSA-N 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 239000003246 corticosteroid Substances 0.000 claims 4
- 231100000321 erythema Toxicity 0.000 claims 4
- IIPYXGDZVMZOAP-UHFFFAOYSA-N lithium nitrate Chemical compound [Li+].[O-][N+]([O-])=O IIPYXGDZVMZOAP-UHFFFAOYSA-N 0.000 claims 4
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 4
- -1 nitrooxymethyl Chemical group 0.000 claims 4
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 4
- 230000000699 topical effect Effects 0.000 claims 4
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 claims 3
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 125000003118 aryl group Chemical group 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 229910052794 bromium Inorganic materials 0.000 claims 3
- 229910052801 chlorine Inorganic materials 0.000 claims 3
- 125000005842 heteroatom Chemical group 0.000 claims 3
- 125000000623 heterocyclic group Chemical group 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 3
- 150000007530 organic bases Chemical class 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Chemical group 0.000 claims 3
- 229920006395 saturated elastomer Polymers 0.000 claims 3
- 125000002345 steroid group Chemical group 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 2
- 206010012442 Dermatitis contact Diseases 0.000 claims 2
- 206010012444 Dermatitis diaper Diseases 0.000 claims 2
- 208000003105 Diaper Rash Diseases 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 2
- 239000002841 Lewis acid Substances 0.000 claims 2
- 229910002651 NO3 Inorganic materials 0.000 claims 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims 2
- 206010033733 Papule Diseases 0.000 claims 2
- 208000003251 Pruritus Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 claims 2
- 208000000260 Warts Diseases 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 2
- 230000000996 additive effect Effects 0.000 claims 2
- 201000008937 atopic dermatitis Diseases 0.000 claims 2
- 208000010668 atopic eczema Diseases 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- 230000000740 bleeding effect Effects 0.000 claims 2
- 238000009835 boiling Methods 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- 208000010247 contact dermatitis Diseases 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 230000003628 erosive effect Effects 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 230000004054 inflammatory process Effects 0.000 claims 2
- 150000007529 inorganic bases Chemical class 0.000 claims 2
- MVFCKEFYUDZOCX-UHFFFAOYSA-N iron(2+);dinitrate Chemical compound [Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MVFCKEFYUDZOCX-UHFFFAOYSA-N 0.000 claims 2
- 230000007803 itching Effects 0.000 claims 2
- 150000007517 lewis acids Chemical class 0.000 claims 2
- 201000011486 lichen planus Diseases 0.000 claims 2
- 239000006210 lotion Substances 0.000 claims 2
- 150000002828 nitro derivatives Chemical class 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- 235000010333 potassium nitrate Nutrition 0.000 claims 2
- 239000004323 potassium nitrate Substances 0.000 claims 2
- 230000001107 psychogenic effect Effects 0.000 claims 2
- 208000008742 seborrheic dermatitis Diseases 0.000 claims 2
- 229910001961 silver nitrate Inorganic materials 0.000 claims 2
- 208000017520 skin disease Diseases 0.000 claims 2
- 201000010153 skin papilloma Diseases 0.000 claims 2
- 235000010344 sodium nitrate Nutrition 0.000 claims 2
- 239000004317 sodium nitrate Substances 0.000 claims 2
- 125000005207 tetraalkylammonium group Chemical group 0.000 claims 2
- 229940041677 topical spray Drugs 0.000 claims 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 claims 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical group C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims 1
- 208000010201 Exanthema Diseases 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 201000005884 exanthem Diseases 0.000 claims 1
- OKDQKPLMQBXTNH-UHFFFAOYSA-N n,n-dimethyl-2h-pyridin-1-amine Chemical compound CN(C)N1CC=CC=C1 OKDQKPLMQBXTNH-UHFFFAOYSA-N 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000012454 non-polar solvent Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 239000002798 polar solvent Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 206010037844 rash Diseases 0.000 claims 1
- 230000003637 steroidlike Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05019155.0 | 2005-09-02 | ||
| EP05019155 | 2005-09-02 | ||
| PCT/EP2006/007746 WO2007025632A2 (en) | 2005-09-02 | 2006-08-04 | Nitrooxy derivatives op glucocorticoids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009506994A JP2009506994A (ja) | 2009-02-19 |
| JP2009506994A5 true JP2009506994A5 (enExample) | 2009-07-16 |
| JP5216589B2 JP5216589B2 (ja) | 2013-06-19 |
Family
ID=37450883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008528372A Expired - Fee Related JP5216589B2 (ja) | 2005-09-02 | 2006-08-04 | ステロイドのニトロオキシ誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| US (5) | US20080221073A1 (enExample) |
| EP (1) | EP1940863B1 (enExample) |
| JP (1) | JP5216589B2 (enExample) |
| KR (1) | KR20080039442A (enExample) |
| CN (2) | CN101300265A (enExample) |
| AR (1) | AR056868A1 (enExample) |
| AU (1) | AU2006286838C1 (enExample) |
| BR (1) | BRPI0614967A2 (enExample) |
| CA (1) | CA2621117A1 (enExample) |
| ES (1) | ES2393363T3 (enExample) |
| IL (2) | IL189337A0 (enExample) |
| NO (1) | NO20081614L (enExample) |
| NZ (1) | NZ566128A (enExample) |
| RU (1) | RU2415864C2 (enExample) |
| SG (1) | SG158916A1 (enExample) |
| TW (1) | TW200801031A (enExample) |
| UY (1) | UY29779A1 (enExample) |
| WO (1) | WO2007025632A2 (enExample) |
| ZA (1) | ZA200801789B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8802726B2 (en) | 2006-02-03 | 2014-08-12 | Nicox S.A. | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies |
| CN101652380A (zh) | 2007-02-05 | 2010-02-17 | 尼科克斯公司 | 释放一氧化氮的类固醇 |
| EP1964550A1 (en) * | 2007-03-01 | 2008-09-03 | NicOx S.A. | Glucocorticoid-nitrooxyderivative compositions |
| ES2324007A1 (es) * | 2007-10-25 | 2009-07-28 | Ferrer Internacional, S.A. | Una forma amorfa de un compuesto antiinflamatorio. |
| EP2318427B1 (en) * | 2008-07-31 | 2013-10-23 | Nicox S.A. | Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| US20110130375A1 (en) * | 2008-08-05 | 2011-06-02 | Nicox S.A. | New no-releasing steroids for the treatment of retina and macula lutea diseases |
| CA2731477A1 (en) * | 2008-08-05 | 2010-02-11 | Nicox S.A. | New no releasing steroids derivatives |
| US8062653B2 (en) * | 2009-02-18 | 2011-11-22 | Bezwada Biomedical, Llc | Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| WO2010096320A2 (en) * | 2009-02-18 | 2010-08-26 | Bezwada Biomedical, Llc | Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| US9022788B2 (en) * | 2009-10-17 | 2015-05-05 | Gregory John Stahler | System and method for cardiac defibrillation response simulation in health training mannequin |
| ES2362894B1 (es) | 2009-11-16 | 2012-05-21 | Ferrer Internacional S.A. | Procedimiento de preparación del �?cido 4-nitro-oxi-metil-benzoico. |
| ES2359708B1 (es) * | 2009-11-16 | 2012-03-30 | Ferrer Internacional S.A. | Procedimiento de preparación de la (11beta,16alfa)-9-fluoro-11-hidroxi-16,17-[1-metil-etilidenebis(oxi)]-21-[1-oxo-[4-(nitrooximetil)benzoxi]]preña-1,4-dien-3,20-diona. |
| EP3525870B1 (en) * | 2016-10-14 | 2023-05-10 | Van Andel Research Institute | Highly potent glucocorticoids |
| US20230131943A1 (en) | 2020-03-24 | 2023-04-27 | Burnet Micheal W | Anti-infective and anti-viral compounds and compositions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1201114A (en) | 1980-02-15 | 1986-02-25 | Gordon H. Phillipps | Androstane carbothioates |
| GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
| US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| US5837698A (en) * | 1996-05-02 | 1998-11-17 | G. D. Searle & Co. | Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs |
| US5985862A (en) * | 1996-05-02 | 1999-11-16 | G.D. Searle & Co. | Pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
| IT1285770B1 (it) * | 1996-10-04 | 1998-06-18 | Nicox Sa | Composti corticoidei |
| IT1311922B1 (it) | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
| EP1336602A1 (en) * | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
-
2006
- 2006-08-04 AU AU2006286838A patent/AU2006286838C1/en not_active Ceased
- 2006-08-04 CN CNA2006800405622A patent/CN101300265A/zh active Pending
- 2006-08-04 SG SG201000520-5A patent/SG158916A1/en unknown
- 2006-08-04 CN CN2011100265155A patent/CN102134269A/zh active Pending
- 2006-08-04 WO PCT/EP2006/007746 patent/WO2007025632A2/en not_active Ceased
- 2006-08-04 BR BRPI0614967-7A patent/BRPI0614967A2/pt not_active IP Right Cessation
- 2006-08-04 US US12/065,561 patent/US20080221073A1/en not_active Abandoned
- 2006-08-04 NZ NZ566128A patent/NZ566128A/en not_active IP Right Cessation
- 2006-08-04 JP JP2008528372A patent/JP5216589B2/ja not_active Expired - Fee Related
- 2006-08-04 ES ES06776617T patent/ES2393363T3/es active Active
- 2006-08-04 RU RU2008111076/04A patent/RU2415864C2/ru not_active IP Right Cessation
- 2006-08-04 CA CA002621117A patent/CA2621117A1/en not_active Abandoned
- 2006-08-04 KR KR1020087004591A patent/KR20080039442A/ko not_active Ceased
- 2006-08-04 EP EP06776617A patent/EP1940863B1/en active Active
- 2006-09-01 AR ARP060103835A patent/AR056868A1/es not_active Application Discontinuation
- 2006-09-01 UY UY29779A patent/UY29779A1/es unknown
- 2006-09-01 TW TW095132322A patent/TW200801031A/zh unknown
-
2008
- 2008-02-07 IL IL189337A patent/IL189337A0/en unknown
- 2008-02-25 ZA ZA200801789A patent/ZA200801789B/xx unknown
- 2008-04-01 NO NO20081614A patent/NO20081614L/no not_active Application Discontinuation
-
2009
- 2009-06-26 US US12/492,359 patent/US20090258849A1/en not_active Abandoned
- 2009-06-26 US US12/492,337 patent/US20090264393A1/en not_active Abandoned
- 2009-06-26 US US12/492,404 patent/US20090264394A1/en not_active Abandoned
-
2011
- 2011-08-10 US US13/207,231 patent/US20110294769A1/en not_active Abandoned
- 2011-11-22 IL IL216516A patent/IL216516A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4242334A (en) | Corticoid 17-(alkyl carbonates) and processes for their preparation | |
| JP2009506994A5 (enExample) | ||
| EP2118120B1 (en) | Nitric oxide releasing steroids | |
| EP3310801B1 (en) | Tgr5 modulators and methods of use thereof | |
| RU2194053C2 (ru) | Производные андростена, фармацевтическая композиция | |
| US20090264393A1 (en) | Nitrooxy derivatives of glucocorticoids | |
| PT85891B (pt) | Processo para a preparacao de 9-alfa-hidroxi-esteroides e dos respectivos derivados 9(11)-deidro bem como de composicoes farmaceuticas que os contem | |
| KR20080091813A (ko) | 신규한 11 베타-히드록시안드로스타-4-엔-3-온 | |
| JP2002542162A (ja) | 医薬化合物 | |
| HU186965B (en) | Process for producing new 6-alpha-methyl-prednisolone derivatives | |
| JPS63501292A (ja) | テトラヒドロ脈管形成抑制ステロイド | |
| CA2731477A1 (en) | New no releasing steroids derivatives | |
| JPS591280B2 (ja) | ステロイダル〔１６α、１７−ｄ〕シクロヘキセン類 | |
| JPH02279697A (ja) | 新規ステロイド化合物およびそれを含む医薬組成物 | |
| JPS5830320B2 (ja) | シンキプレグナンサンユウドウタイ ノ セイホウ | |
| JPS5912680B2 (ja) | プレグナン酸誘導体の製法 | |
| Łotowski et al. | New acyclic dimers of cholic acid with oxamide and hydrazide spacers | |
| EP1395544A1 (en) | Methods of making 21- 4'-(nitrooxyalkyl) benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof | |
| JPH0762028B2 (ja) | 新規１６，１７−アセタ−ル置換アンドロスタン−１７β−カルボン酸エステル | |
| JPS6246557B2 (enExample) | ||
| Srivastava et al. | An expedient synthesis spectral characteristic computational studies and target prediction through insilco studies of 24α-ethylcholest-5, 22E-dien-3-yl-2-mercapto-benzoate and 11, 17 di-hydroxy preg-4-ene-3, 20-dione-21-yl-2-mercapto-benzoate | |
| HK1124617A (en) | Nitrooxy derivatives op glucocorticoids | |
| JPS5942399A (ja) | ステロイド性９，１１β−ジハロ−〔１６α，１７−ｂ〕〔１，４〕ジオキシン類の製造法 | |
| MX2008003029A (en) | Nitrooxy derivatives op glucocorticoids | |
| JPH0273099A (ja) | ２１−アシルオキシ−２０−ケト−デルタ↑１↑６−ステロイドの製造法 |